Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07042581 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Revaree Plus in People With Breast Cancer

StatusRecruiting
PhasePhase 4
Started2025-06-20
View on ClinicalTrials.gov ↗

Amendment history

2026-02-04
Study Status v2
Re-verified, no change to tracked fields
2025-11-12
Study Status, Eligibility v1
Eligibility criteria+88 characters
[...] glish or Spanish Breast cancer patients must have completed primary therapy (surgery, and/or chemotherapy, and/or radiation therapy) (andor can becurrently on maintenance therapy) Currently on an aromatase inhibitor or tamoxifen or Selective Estrogen Receptor Modulators (SERM) Currently have no clinical evidence of disease Reporting be [...]
2025-06-20
Original filing
The purpose of this study is to find out whether Revaree Plus is effective at improving vaginal health for people who are having symptoms of vaginal dryness during breast cancer treatment.
Trial Details
NCT Number NCT07042581
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions Breast Cancer, Stage 0 Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer, Stage 0 Breast Carcinoma, Stage II Breast Carcinoma, Stage III Breast Carcinoma +3 more
Enrollment 60 participants
Start Date 2025-06-20
Primary Completion 2029-06-20 (estimated)
Study Completion 2029-06-20 (estimated)
Updated on ClinicalTrials.gov 2026-02-06